科特克公司欢迎弗兰克·德西雷博士担任首席执行官-动脉网

CorTec Welcomes Dr. Frank Desiere as Chief Executive Officer

D-Pharm 等信源发布 2025-03-27 12:58



可切换为仅中文







CorTec GmbH, a pioneer in active implantable technologies and Brain-Computer Interface (BCI) systems, is pleased to announce the appointment of Dr. Frank Desiere as its new Chief Executive Officer (CEO). This significant leadership milestone highlights CorTec’s commitment to driving innovation and growth in the rapidly evolving .

CorTec GmbH是一家在主动植入技术及脑机接口（BCI）系统领域的先锋企业，欣然宣布任命弗兰克·德西雷博士为新任首席执行官（CEO）。这一重要的领导层里程碑凸显了CorTec致力于在快速发展的行业中推动创新与增长的承诺。

neurotechnology

神经科技

sector.

部门。

CorTec GmbH

科特克有限公司

The appointment of Dr. Frank Desiere as new CEO marks a pivotal moment for CorTec, leveraging his vast experience to expand its impact in the rapidly growing Neurotech industry. Dr. Oliver Baertl, in the role of COO, will be focusing on leading the component business for active implantable technologies and ensuring operational excellence.

弗兰克·德西雷博士被任命为新任首席执行官，这标志着科特克公司迎来了一个关键转折点，将利用他丰富的经验扩大其在快速发展的神经科技行业中的影响力。奥利弗·贝尔特尔博士担任首席运营官，将专注于领导用于植入式技术的组件业务，并确保卓越的运营。

CTO Dr. Martin Schuettler, will continue to lead technological advancements and sustained innovation. The strengthened leadership team displays CorTec’s dedication to addressing the dynamic needs of the medical device sector while unlocking new opportunities within the field of Brain-Computer Interfaces..

首席技术官马丁·舒特勒博士将继续引领技术进步和持续创新。这支更强大的领导团队展示了CorTec致力于满足医疗器械领域的动态需求，同时在脑机接口领域开拓新机遇的决心。

Introducing Dr. Frank Desiere: A Visionary Leader

介绍弗兰克·德西雷博士：一位富有远见的领导者

Dr. Frank Desiere brings a wealth of experience and a proven track record in the Medical Device and Life Science industry. Holding a PhD in Life Sciences from ETH Zuerich and an MBA from IMD Lausanne, Dr. Desiere has held senior leadership roles at global organizations, including Roche, where he spearheaded business development initiatives and introduced groundbreaking MedTech innovations and digital health solutions.

弗兰克·德西雷博士在医疗器械和生命科学行业拥有丰富的经验以及经过验证的成功记录。他持有苏黎世联邦理工学院的生命科学博士学位以及洛桑国际管理学院的工商管理硕士学位。德西雷博士曾在罗氏等全球性组织中担任高级领导职务，领导了业务发展计划，并引入了突破性的医疗技术革新和数字健康解决方案。

His expertise spans fostering strategic partnerships, driving technology transfer, and leading digital transformation – all central capabilities that align perfectly with CorTec’s vision for shaping the future of Neurotechnology..

他的专业知识涵盖促进战略合作伙伴关系、推动技术转让和引领数字化转型——所有这些核心能力与CorTec塑造神经技术未来的愿景完美契合。

“I am thrilled to join CorTec at such an exciting time,” said Dr. Frank Desiere. “The company is at the forefront of active implantable technologies and systems and has a bold vision for the future.

“我非常高兴在这个令人兴奋的时刻加入CorTec，”弗兰克·德西雷博士说道。“公司处于主动植入技术与系统的前沿，并且对未来有着大胆的愿景。

Together with this talented team, we will achieve remarkable breakthroughs, strengthen our position as a technology leader, and unlock new growth opportunities.”

与这支才华横溢的团队一起，我们将取得显著的突破，巩固我们作为技术领导者的地位，并开拓新的增长机会。

A Unified Vision for the Future

对未来的统一愿景

Dr. Oliver Baertl expressed his enthusiasm: “We will be able to further advance our active implantable technologies within the strategic partnership with Heraeus Medevio, while at the same time positioning CorTec in the rapidly growing BCI segment. I am excited to work with Frank, Martin, and the team to drive CorTec’s strategy forward and to empower our partners and customers to realize medical device innovations.”.

奥利弗·贝尔特博士表示：“在与贺利氏医疗事业部的战略合作中，我们将能够进一步推进我们的有源植入技术，同时将CorTec定位在快速发展的脑机接口领域。我期待与弗兰克、马丁以及团队一起推动CorTec的战略发展，并帮助我们的合作伙伴和客户实现医疗器械的创新。”

Commenting on the new leadership structure, Chairman of the Board, Dr. Christoph Mangold adds: “The onboarding of Dr. Frank Desiere as CEO and the composition of a strong leadership team is a clear statement about CorTec’s ambitious plans in the market. This will unlock new strategic opportunities and drive groundbreaking innovation in both the component and BCI segments.”.

董事会主席克里斯托夫·曼戈尔德博士在评论新的领导结构时补充道：“Frank Desiere博士作为首席执行官的上任以及强大领导团队的组建，清楚地表明了CorTec在市场上的雄心壮志。这将开启新的战略机遇，并推动组件和脑机接口（BCI）领域的突破性创新。”

CorTec is now well positioned to become the Development and Manufacturing partner of choice for implantable technologies and to drive exceptional growth.

科特克公司现在已准备好成为植入式技术的首选开发和制造合作伙伴，并推动卓越的增长。

https://www.bionity.com/en/news/1185891/cortec-welcomes-dr-frank-desiere-as-chief-executive-officer.html

https://www.bionity.com/zh/news/1185891/cortec-欢迎-dr-frank-desiere-担任首席执行官.html

30 million euros: Cottbus start-up receives largest research funding in Europe

3000万欧元：科特布斯初创公司获得欧洲最大研究资助

Cyberagentur finances revolution in neuro-adaptive human-machine interaction

网络代理机构资助神经适应性人机交互革命

Read news

读新闻